Sunday 29 June 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
June
(40)
- Plethico plans to cut CMO business
- Rentschler Biotechnologie has started operation of...
- Emcure inaugurates plants
- Chemtura has ended plans for a sale
- Hovione saw sales rise 11% to $103.7m in the year ...
- RFCL is set to acquire Italian chemicals manufactu...
- Cobra Biomanufacturing revenues fall in 2007 leadi...
- PCI synthesis passes FDA audit at Devens, MA facility
- FDA funding approved
- Avid joins PER-C6 network
- Saltigo expects to meet 5% profit goal
- DHS notifies high risk facilities
- Reaxa adds iridium removal to its precious metal s...
- Pfizer quashes Ranbaxy buy-out rumours
- Avecia will manufacture clinical trial materials f...
- PacificGMP will build biomanufacturing facility in...
- China grants approval for FDA offices
- US Senator calls for pharma outsourcing probe
- Eden Biodesign is to build a biomanufacturing faci...
- CEFIC and DSM criticise EU API measures
- Dishman builds in China
- FDA considers outsourcing inspections
- Further production boost for PER-C6
- Evonik may sell more shares
- Daiichi to acquire Ranbaxy stake
- pecter slams Administration over FDA cash
- BASF has developed a new class of enzymes for prod...
- Avecia has added formulation studies to its portfolio
- Angel Biotechnology will manufacture GMP clinical ...
- Arch buys into Benzochem
- Administration asks for more cash for FDA
- Cobra Biomanufacturing will produce ViroMed’s Mast...
- Cambridge Major has broken ground on its expansion...
- Matthey takes stake in Dr Reddy's subsidiary
- Johnson Matthey's Fine Chemicals and Catalysts bus...
- Central Glass acquires Girindus business
- CVC wins Evonik race, IPO planned
- Dow Chemical has settled its litigation against fo...
- CVC expected to win Evonik race
- Evonik decision due 11 June
-
▼
June
(40)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment